Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating expenses
General and administrative	$ 1,249,961	$ 1,360,138
Research and development	345,969	746,371
Depreciation and amortization	37,240	81,024
Total operating expenses	1,633,170	2,187,533
Loss from operations	(1,633,170)	(2,187,533)
Other (expense) income
Other income		2,565
Interest (expense) income, net	(303)	2
Total other (expense) income	(303)	2,567
Net loss before income taxes	(1,633,473)	(2,184,966)
Income tax expense
Net loss	(1,633,473)	(2,184,966)
Other comprehensive loss
Foreign currency translation	(7,018)	(3,487)
Comprehensive loss	$ (1,640,491)	$ (2,188,453)
Net loss per share - basic	$ (1.08)	$ (14.58)
Net loss per share - diluted	$ (1.08)	$ (14.58)
Weighted average shares outstanding, basic	1,510,401	149,815
Weighted average shares outstanding, diluted	1,510,401	149,815